Vident Partners provides vetted geriatric psychiatry expert witnesses for cases involving antipsychotic chemical restraint in nursing homes, medication management in dementia, elopement and elder suicide, testamentary and decisional capacity, and undue influence in contested estates. Request a referral today.
Find a Geriatric Psychiatry Expert →Overview
Geriatric psychiatry experts address psychiatric illness in older adults, where dementia, delirium, medical comorbidity, and polypharmacy interact in ways that ordinary adult psychiatry does not confront. Subspecialty certification is administered by the American Board of Psychiatry and Neurology: applicants must already be ABPN-certified in general psychiatry and must complete one year of ACGME-accredited fellowship training in geriatric psychiatry, taken in a continuous block of at least half time 1. In litigation these experts occupy two distinct roles -- standard-of-care witness in facility and prescribing cases, and capacity witness in probate and civil competency disputes -- and counsel should be explicit about which role is being retained.
The largest body of standard-of-care work involves psychotropic prescribing in long-term care. Every FDA-approved antipsychotic carries a boxed warning that elderly patients with dementia-related psychosis treated with antipsychotic drugs are at an increased risk of death, and these drugs are not approved for use in dementia-related psychosis 2. The supporting analysis of 17 placebo-controlled trials, modal duration 10 weeks, found a risk of death in drug-treated patients of 1.6 to 1.7 times that of placebo-treated patients -- roughly 4.5 percent versus 2.6 percent -- with most deaths cardiovascular or infectious in nature 2.
Federal nursing home regulations convert that pharmacology into an enforceable standard. Under 42 CFR 483.45, each resident's drug regimen must be reviewed at least monthly by a licensed pharmacist; residents who use psychotropic drugs must receive gradual dose reductions and behavioral interventions unless clinically contraindicated, in an effort to discontinue the drugs; PRN orders for psychotropic drugs are limited to 14 days; and PRN orders for antipsychotics are limited to 14 days and cannot be renewed unless the prescriber evaluates the resident for the appropriateness of that medication 3. The American Geriatrics Society Beers Criteria, updated in 2023, provide the companion clinical reference: an explicit list of potentially inappropriate medications best avoided by adults 65 and older across ambulatory, acute, and institutional settings 4. In hospital settings, the restraint and seclusion Conditions of Participation apply, permitting restraint only to ensure immediate physical safety, requiring discontinuation at the earliest possible time, and prohibiting standing or PRN restraint orders 5. Together, these provisions supply the framework for the chemical-restraint theory that drives much nursing home psychiatric litigation.
The capacity side of the practice is entirely separate. Geriatric psychiatrists are retained to opine retrospectively on testamentary capacity, contractual capacity, capacity to consent to medical treatment or to a settlement, susceptibility to undue influence, and the need for guardianship or conservatorship. That opinion is usually reconstructed from medical records, medication lists, cognitive testing, and witness accounts rather than from a live examination, so the expert's methodology -- and the extent to which it can be replicated -- becomes the focus of Daubert challenges. Other recurring matters include elopement and wandering deaths, failure to assess suicide risk in older adults, delirium misdiagnosed as dementia, and failure to recognize and report elder abuse or financial exploitation.
FDA analyses of 17 placebo-controlled trials found that elderly patients with dementia-related psychosis treated with antipsychotic drugs died at 1.6 to 1.7 times the rate of placebo-treated patients — about 4.5 percent versus 2.6 percent over a typical 10-week trial.
Case Types
Antipsychotic chemical restraint and unnecessary psychotropic use in nursing homes
Failure to perform gradual dose reduction or monthly drug regimen review under federal long-term care rules
Testamentary capacity, undue influence, and contested guardianship or conservatorship
Elder suicide and inadequate psychiatric risk assessment in older adults
Elopement, wandering, and failure to supervise residents with dementia
Delirium misdiagnosed as dementia and consequent treatment failure
Qualifications
Related Specialties
FAQ
The expert should hold ABPN subspecialty certification in geriatric psychiatry, which requires prior ABPN certification in general psychiatry plus one year of ACGME-accredited geriatric psychiatry fellowship training. For nursing home cases, current practice in long-term care and familiarity with federal psychotropic drug regulations matter more than academic appointment; for capacity cases, a documented and replicable evaluation methodology is the decisive credential.
These experts are retained in nursing home chemical restraint and psychotropic overmedication claims, elder suicide and failure-to-assess cases, elopement and wandering deaths, delirium misdiagnosis, and probate and civil disputes over testamentary capacity, decisional capacity, undue influence, and guardianship.
It is the allegation that antipsychotics were used to sedate a resident for staff convenience rather than to treat a documented psychiatric condition. Federal rules give the theory structure: 42 CFR 483.45 requires monthly pharmacist drug regimen review, requires gradual dose reduction and behavioral interventions unless clinically contraindicated, limits PRN psychotropic orders to 14 days, and bars renewal of PRN antipsychotic orders without a prescriber evaluation. FDA labeling separately warns that antipsychotics increase mortality in elderly patients with dementia-related psychosis and are not approved for that use.
Yes. Retrospective capacity opinions are routine in will contests and undue influence claims and are typically reconstructed from medical and pharmacy records, cognitive testing performed during life, and witness accounts rather than a live examination. Because there is no contemporaneous examination, courts scrutinize methodology closely, so the expert should be able to state the criteria applied, the records relied on, and the limits of the opinion.
In general, medical expert fees are determined by the expert themselves, based on a variety of criteria. Among those criteria are clinical experience, forensic experience, academic qualifications such as Fellowships, clinical settings, and publications. Vident does have some influence over expert fees by comparing experts within a specialty, but ultimately it is a personal decision by the expert.
Related Insights
Psychiatry has several recognized subspecialties that focus on different patient populations, clinical issues, or intersections with other medical fields. The main psychiatry subspecialties include:...
Practice Area IntelligenceOver the past several years I have reviewed medical charts for both insurance companies and pain clinics to determine if what has been recorded makes good medical sense and shows an appropriate level...
Research BriefingFentanyl, a synthetic opioid, was first developed by Dr. Paul Janssen in the 1960s. From its inception, it was designed to be fast-acting, highly potent, and more readily synthesized than naturally oc...
Sources
Vident Partners connects attorneys with qualified geriatric psychiatry expert witnesses. Complimentary consultation, 24-hour turnaround, no obligation.
Request an Expert →